Diabetes and metabolic dysfunction-associated fatty liver disease
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 123, 154868
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseGastroenterology, 2013
- Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopyJournal of Magnetic Resonance Imaging, 2011
- Hepatic Steatosis in Type 1 DiabetesThe Review of Diabetic Studies, 2011
- A simple index of lipid overaccumulation is a good marker of liver steatosisBMC Gastroenterology, 2010
- Physicians’ attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regionsCurrent Medical Research and Opinion, 2009
- Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosisHepatology, 2008
- Improved survival in both men and women with diabetes between 1980 and 2004 – a cohort study in SwedenCardiovascular Diabetology, 2008
- Comparison of CT Methods for Determining the Fat Content of the LiverAmerican Journal of Roentgenology, 2007
- The NAFLD fibrosis scoreHepatology, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006